Advanced search
Publication Cover
Current Medical Research and Opinion Volume 21, 2005 - Issue 11
Submit an article Journal homepage
107
Views
22
CrossRef citations to date
0
Altmetric
Original Article

The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss

Rachel Rowe Wythenshawe Hospital, Manchester, UK
,
Margaret Cowx Wythenshawe Hospital, Manchester, UK
,
Chris Poole Cardiff Research Consortium, Cardiff, UK
,
Phil McEwan Cardiff Research Consortium, Cardiff, UKCorrespondence[email protected]
,
Christopher Morgan School of Medicine, Cardiff University, Cardiff, UK
&
Mel Walker Roche–UK, Welwyn Garden City, UK
Pages 1885-1890 | Accepted 29 Sep 2005, Published online: 18 Oct 2005

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lina Shibib, Mo Al-Qaisi, Ahmed Ahmed, Alexander D Miras, David Nott, Marc Pelling, Stephen E Greenwald & Nicola Guess. (2022) Reversal and Remission of T2DM – An Update for Practitioners. Vascular Health and Risk Management 18, pages 417-443.
Read now
Katie S McClendon, Daniel M Riche & Gabriel Ikponmosa Uwaifo. (2009) Orlistat: current status in clinical therapeutics. Expert Opinion on Drug Safety 8:6, pages 727-744.
Read now

Articles from other publishers (20)

Veronica F Salau, Ochuko L Erukainure, Omamuyovwi M Ijomone & Md. Shahidul Islam. (2022) Caffeic acid regulates glucose homeostasis and inhibits purinergic and cholinergic activities while abating oxidative stress and dyslipidaemia in fructose-streptozotocin-induced diabetic rats. Journal of Pharmacy and Pharmacology 74:7, pages 973-984.
Crossref
Nadia N. Ahmad, Susan Robinson, Tessa Kennedy‐Martin, Jiat Ling Poon & Hong Kan. (2021) Clinical outcomes associated with anti‐obesity medications in real‐world practice: A systematic literature review. Obesity Reviews 22:11.
Crossref
Bernardo M. Pessoa, Matthew G. Browning, Guilherme S. Mazzini, Luke Wolfe, Amy Kaplan, Jad Khoraki & Guilherme M. Campos. (2020) Factors Mediating Type 2 Diabetes Remission and Relapse after Gastric Bypass Surgery. Journal of the American College of Surgeons 230:1, pages 7-16.
Crossref
Mohammed Alkharaiji, Uchenna Anyanwagu, Richard Donnelly & Iskandar Idris. (2019) Tier 3 specialist weight management service and pre-bariatric multicomponent weight management programmes for adults with obesity living in the UK: A systematic review. Endocrinology, Diabetes & Metabolism 2:1, pages e00042.
Crossref
Alison Avenell, Clare Robertson, Zoë Skea, Elisabet Jacobsen, Dwayne Boyers, David Cooper, Magaly Aceves-Martins, Lise Retat, Cynthia Fraser, Paul Aveyard, Fiona Stewart, Graeme MacLennan, Laura Webber, Emily Corbould, Benshuai Xu, Abbygail Jaccard, Bonnie Boyle, Eilidh Duncan, Michal Shimonovich & Marijn de Bruin. (2018) Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation. Health Technology Assessment 22:68, pages 1-246.
Crossref
A. M. Mkrtumyan & E. V. Biryukova. (2017) ORLISTAT IN COMBINATION THERAPY OF OBESITY AND TYPE 2 DIABETES. Medical Council:3, pages 68-74.
Crossref
Adrian Brown, Nicola Guess, Anne Dornhorst, Shahrad Taheri & Gary Frost. (2017) Insulin‐associated weight gain in obese type 2 diabetes mellitus patients: What can be done?. Diabetes, Obesity and Metabolism 19:12, pages 1655-1668.
Crossref
T. J. Brown, C. O'Malley, J. Blackshaw, V. Coulton, A. Tedstone, C. Summerbell & L. J. Ells. (2017) Exploring the evidence base for Tier 3 weight management interventions for adults: a systematic review. Clinical Obesity 7:5, pages 260-272.
Crossref
W S Leslie, R Taylor, L Harris & M E J Lean. (2016) Weight losses with low-energy formula diets in obese patients with and without type 2 diabetes: systematic review and meta-analysis. International Journal of Obesity 41:1, pages 96-101.
Crossref
Wilma S. Leslie, Ian Ford, Naveed Sattar, Kieren G. Hollingsworth, Ashley Adamson, Falko F. Sniehotta, Louise McCombie, Naomi Brosnahan, Hazel Ross, John C. Mathers, Carl Peters, George Thom, Alison Barnes, Sharon Kean, Yvonne McIlvenna, Angela Rodrigues, Lucia Rehackova, Sviatlana Zhyzhneuskaya, Roy Taylor & Mike E. J. Lean. (2016) The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial. BMC Family Practice 17:1.
Crossref
M Feigh, KV Andreassen, AV Neutzsky‐Wulff, ST Petersen, C Hansen, AC Bay‐Jensen, JE Henriksen, H Beck‐Nielsen, C Christiansen, K Henriksen & MA Karsdal. (2012) Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta‐cell area and function in Zucker diabetic fatty rats. British Journal of Pharmacology 167:1, pages 151-163.
Crossref
Debasis Bagchi & Harry PreussSubhashini Yaturu & Sushil Jain. 2012. Obesity. Obesity 211 238 .
C. Ll. Morgan, S. Jenkins‐Jones, M. Evans, A. H. Barnett, C. D. Poole & C. J. Currie. (2012) Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs. Diabetes, Obesity and Metabolism 14:5, pages 424-432.
Crossref
Subhashini Yaturu. (2011) Obesity and type 2 diabetes. Journal of Diabetes Mellitus 01:04, pages 79-95.
Crossref
S. Jacob, M. Rabbia, M. K. Meier & J. Hauptman. (2009) Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss. Diabetes, Obesity and Metabolism 11:4, pages 361-371.
Crossref
P. J. Larsen, E. M. Wulff, C. F. Gotfredsen, C. L. Brand, J. Sturis, N. Vrang, L. B. Knudsen & K. Lykkegaard. (2008) Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats. Diabetes, Obesity and Metabolism 10:4, pages 301-311.
Crossref
Subhashini Yaturu & Sushil Jain. 2007. Obesity. Obesity 139 154 .
Aviv Tuttnauer & Phillip D. Levin. (2006) Diabetes Mellitus and Anesthesia. Anesthesiology Clinics of North America 24:3, pages 579-597.
Crossref
Juliet M. Mancino. (2006) Orlistat: Current issues for patients with type 2 diabetes. Current Diabetes Reports 6:5, pages 389-394.
Crossref
Sheridan Henness & Caroline M Perry. (2006) Orlistat. Drugs 66:12, pages 1625-1656.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.